LIFR and prostate cancer: Utilizing the Oncomine platform54 and cBioPortal web resource40 to analyze LIFR expression and genetic alterations in cancer genomics datasets, we observed that LIFR is overexpressed in melanomas, CNS tumors, lymphomas, and prostate cancers, but downregulated in breast, colorectal, and lung cancers.